Editas Medicine (EDIT) Non-cash Items (2015 - 2023)

Editas Medicine (EDIT) has 9 years of Non-cash Items data on file, last reported at $466.2 million in Q2 2023.

• Quarterly Non-cash Items fell 55.85% year-over-year to $466.2 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $466.2 million (down 55.85% YoY) and the FY2022 annual result came in at $2.0 million, down 99.96% from the prior year.
• Non-cash Items grew to $466.2 million in Q2 2023 per EDIT's latest filing, from $236.5 million in the prior quarter.
• Across five years, Non-cash Items topped out at $5.1 billion in Q4 2021 and bottomed at $1.3 million in Q2 2021.
• The 5-year median for Non-cash Items is $27.2 million (2019), against an average of $636.6 million.
• The widest annual swing landed in 2019, when Non-cash Items sank 96.34%; it then soared 84082.26% in 2022.
• Tracing EDIT's Non-cash Items over 5 years: stood at $26.1 million in 2019, then soared by 543.28% to $167.6 million in 2020, then jumped by 2913.88% to $5.1 billion in 2021, then tumbled by 92.05% to $401.5 million in 2022, then climbed by 16.11% to $466.2 million in 2023.
• Per Business Quant, the three latest EDIT Non-cash Items figures stand at $466.2 million (Q2 2023), $236.5 million (Q1 2023), and $401.5 million (Q4 2022).

Peer Comparison